May 2018 FDA Recall Valsartan by Jubilant Cadista Pharmaceuticals, Inc.
D-0876-2018 - Incorrect/Undeclared excipient

This Class III drug recall was voluntarily initiated by Jubilant Cadista Pharmaceuticals, Inc. on May 25, 2018 for the product Valsartan. The FDA reported the reason for recall as incorrect/undeclared excipient. The product was distributed in IN, MI, MS, NC, NJ, NY and OH and the recall is currently terminated.

Recall Number: D-0876-2018

Reason for Recall
Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).
Initiated
05-25-2018
Reported
06-13-2018
Quantity
2,328 bottles (Lot VR417065A) and 2,352 bottles (Lot VR417066A)

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Jubilant Cadista Pharmaceuticals, Inc.
IN, MI, MS, NC, NJ, NY and OH
Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90

Batch or Lot Expiration Information

Lot# : VR417065A, VR417066A, Exp 10/2019